MEGA-PURE (MGF) by Meditech is a pharmaceutical-grade Mechano Growth Factor lyophilized injectable peptide formulation at 2000 mcg per vial. Mechano Growth Factor is a splice variant of the IGF-1 gene produced endogenously in mechanically stressed muscle tissue, with an established and growing research history in muscle biology, exercise physiology, and regenerative peptide pharmacology literature. As a distinct IGF-1 isoform rather than a systemic growth factor, MGF is investigated for its localized and temporally specific role in the muscle repair and satellite cell activation cascade following mechanical loading — representing a pharmacologically distinct research profile relative to both systemic IGF-1 and growth hormone secretagogue peptides.
 
✔ Key Research Insights
Studied for its role as a locally expressed IGF-1 splice variant in mechanically stressed muscle tissue, with documented activation of muscle satellite cells — the primary precursor cells responsible for muscle fiber repair and new myofibrillar growth — in exercise physiology and muscle biology research
Investigated for its distinct N-terminal peptide extension sequence, documented to confer receptor binding and biological activity profiles distinct from systemic IGF-1 in comparative growth factor pharmacology research
Researched for its influence on muscle protein synthesis and myofibrillar hypertrophy parameters following mechanical loading in documented subject populations across muscle biology research literature
Examined for its documented temporal expression pattern in mechanically loaded muscle, with endogenous MGF levels peaking in the immediate post-exercise window — a pharmacokinetic characteristic of clinical relevance to administration timing protocols in research settings
Documented for its anti-catabolic properties, with investigated effects on muscle protein breakdown inhibition and regenerative signaling in research subject populations across comparative peptide research
Researched for its localized activity profile, with intramuscular administration at specific tissue sites documented as the primary administration route in research protocols examining targeted muscle repair parameters
Manufactured by Meditech to pharmaceutical-grade lyophilized peptide purity and formulation standards
 
📦 Product Specifications
Manufacturer: Meditech
Product: MEGA-PURE
Molecule: Mechano Growth Factor (MGF)
Concentration: 2000 mcg per vial
Appearance: Lyophilized white powder
Form: Injectable peptide requiring reconstitution prior to administration
Administration: Intramuscular injection at target tissue sites per documented research protocols
Dosage considerations may vary. Consulting a qualified professional is recommended.
 
⚙ How It Works
Mechano Growth Factor is an alternatively spliced isoform of the IGF-1 gene produced in skeletal muscle tissue in response to mechanical stress and microtrauma induced by resistance exercise or physical loading. Unlike systemic IGF-1, which is produced primarily in the liver and circulates throughout the body, endogenous MGF is expressed locally within mechanically stressed muscle fibers and acts in a paracrine and autocrine fashion on surrounding satellite cells — the adult muscle stem cell population responsible for muscle fiber repair, regeneration, and hypertrophy. In research subjects, the distinct E-domain peptide sequence unique to the MGF isoform has been documented to activate quiescent satellite cells, stimulating their proliferation and differentiation into new myonuclei that fuse with existing muscle fibers to support repair and growth. This satellite cell activation mechanism is documented in muscle biology research as a critical rate-limiting step in the muscle hypertrophy response to mechanical loading, and represents the primary pharmacological research interest of exogenous MGF administration in peptide research protocols. The temporal specificity of endogenous MGF expression — peaking in the immediate post-exercise window before declining rapidly — informs the intramuscular administration timing protocols examined in MGF research, where post-exercise local injection has been investigated for its capacity to amplify the endogenous satellite cell activation signal. The downstream effects on protein synthesis and myofibrillar remodeling documented across MGF research literature are mediated through both satellite cell-dependent and direct anabolic receptor signaling pathways distinct from those of systemic IGF-1. Reconstitution with bacteriostatic water is standard protocol prior to intramuscular administration in documented research settings, with lyophilized storage ensuring peptide stability and bioactivity prior to use.
 
⭐ Product Overview
Manufactured by Meditech to pharmaceutical-grade lyophilized peptide purity and formulation standards
IGF-1 splice variant peptide with a pharmacologically distinct localized satellite cell activation mechanism documented in muscle biology and exercise physiology research literature
Temporally and spatially specific research profile — locally expressed in mechanically stressed muscle tissue with a distinct post-exercise activity window — representing a unique pharmacological research interest relative to systemic growth factor peptides
Available in lyophilized vial format at 2000 mcg per vial, requiring reconstitution prior to intramuscular administration per standard peptide research protocols
Widely referenced in muscle biology, exercise physiology, and regenerative peptide pharmacology research under the Mechano Growth Factor and MGF designations